Performance and Practice Guideline for the Use of Neoadjuvant Systemic Therapy in the Management of Breast Cancer-Reference-Cited by-同舟云学术

Performance and Practice Guideline for the Use of Neoadjuvant Systemic Therapy in the Management of Breast Cancer

Published:2015-07-30 Issue:10 Volume:22 Page:3184-3190
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Holmes Dennis,Colfry A.,Czerniecki Brian,Dickson-Witmer Diana,Francisco Espinel C.,Feldman Elizabeth,Gallagher Kristalyn,Greenup Rachel,Herrmann Virginia,Kuerer Henry,Malik Manmeet,Manahan Eric,O’Neill Jennifer,Patel Mita,Sebastian Molly,Wheeler Amanda,Kass Rena

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-015-4753-3.pdf

Reference43 articles.

1. Wolmark N, Wang J, Mamounas E, et al. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr. 2001;(30):96–102.

2. Van der Hage JA, van de Velde CJ, Julien JP, et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer Trial 10902. J Clin Oncol. 2001;19:4224–37.

3. Gianni L, Baselga J, Eirmann W, et al. European Cooperative Trial in Operable Breast Cancer (ECTO): improved freedom from progression (FFP) from adding paclitaxel (T) to doxorubicin (A) followed by cyclophosphamide methotrexate and fluorouracil (CMF) (abstract 513). J Clin Oncol. 2005;23:7s.

4. Bear HD, Anderson S, Brown A, et al. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol. 2003;21:4165–74.

5. Gianni L, Baselga J, Eiermann W, et al. First report of the European Cooperative Trial in Operable Breast Cancer (ECTO): effect of primary systemic therapy (abstract 132). Proc Am Soc Clin Oncol. 2002;21:34a.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Neoadjuvant Chemotherapy With Postoperative Outcomes in Immediate Prepectoral Prosthetic Breast Reconstruction;Annals of Plastic Surgery;2024-05

2. Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients;BMC Women's Health;2024-03-20

3. Reducing the Risk of Needle Tract Seeding or Tumor Cell Dissemination during Needle Biopsy Procedures;Cancers;2024-01-11

4. Oncologic Outcomes of Immediate Breast Reconstruction in the Setting of Neoadjuvant Chemotherapy: A Long-term Follow-up Study of a Matched Cohort;Journal of Breast Cancer;2024

5. Value of ultrasound in assessing response to neoadjuvant chemotherapy in breast cancer;Clinical Radiology;2023-12